Squarer Ron

Director at Travere Therapeutics, Inc. · on record since May 21, 2026
Director at Nuvalent, Inc. · on record since Dec 11, 2025
Chief Commercial Officer at HOSPIRA INC · on record since Apr 1, 2010
Director at ARRAY BIOPHARMA INC · on record since Apr 30, 2012
Director at ADC TELECOMMUNICATIONS INC · on record since Jun 3, 2026
CEO at ARRAY BIOPHARMA INC · on record since Apr 3, 2014
Director at Deciphera Pharmaceuticals, Inc. · on record since Dec 6, 2019

Insider trading activity of Squarer Ron

Transactions on record: 145; since Feb 26, 2009

Open-market buys: 1; $74.4K

Open-market sells: 11; $20.7M

Companies traded: 6; last filing Jun 18, 2026

Figures computed from official regulatory filings — methodology.

Companies where Squarer Ron has traded

Nuvalent, Inc.3 tx · Jun 18, 2026
ADC TELECOMMUNICATIONS INC6 tx · $121.4K · Jun 3, 2026
Travere Therapeutics, Inc.20 tx · May 21, 2026
Deciphera Pharmaceuticals, Inc.15 tx · $225K · Jun 11, 2024
ARRAY BIOPHARMA INC77 tx · $42M · Jul 30, 2019
HOSPIRA INC24 tx · $3.3M · Feb 28, 2011

Track record of Squarer Ron

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Squarer Ron

Co-insiders of Squarer Ron

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Nuvalent, Inc.	Jun 18, 2026	Award	3,444	0.00 USD	—	SEC
ADC TELECOMMUNICATIONS INC	Jun 3, 2026	Other	-15,196	3.08 USD	$46.8K	SEC
ADC TELECOMMUNICATIONS INC	Jun 3, 2026	Award	45,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	AwardD	12,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	Award	4,000	0.00 USD	$0	SEC
Nuvalent, Inc.	Dec 11, 2025	AwardD	4,418	0.00 USD	$0	SEC
Nuvalent, Inc.	Dec 11, 2025	Award	2,837	0.00 USD	$0	SEC
ADC TELECOMMUNICATIONS INC	Jun 17, 2025	Other	-15,184	3.58 USD	$54.4K	SEC
ADC TELECOMMUNICATIONS INC	Jun 5, 2025	Award	40,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 16, 2025	Award	6,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 16, 2025	AwardD	19,500	0.00 USD	$0	SEC
ADC TELECOMMUNICATIONS INC	Jun 18, 2024	Sell	-6,995	2.89 USD	$20.2K	SEC
ADC TELECOMMUNICATIONS INC	Jun 14, 2024	Award	40,000	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-3,269	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-9,570	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-18,500	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-4,727	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-30,000	—	—	SEC
Travere Therapeutics, Inc.	May 10, 2024	Award	6,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 10, 2024	AwardD	19,500	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jan 18, 2024	AwardD	4,727	10.58 USD	$50K	SEC
Deciphera Pharmaceuticals, Inc.	Jun 23, 2023	AwardD	30,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 19, 2023	Award	4,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 19, 2023	AwardD	13,500	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jan 19, 2023	AwardD	3,269	15.30 USD	$50K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Nuvalent, Inc.	Jun 18, 2026	Award	3,444	0.00 USD	—	SEC
ADC TELECOMMUNICATIONS INC	Jun 3, 2026	Other	-15,196	3.08 USD	$46.8K	SEC
ADC TELECOMMUNICATIONS INC	Jun 3, 2026	Award	45,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	AwardD	12,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 21, 2026	Award	4,000	0.00 USD	$0	SEC
Nuvalent, Inc.	Dec 11, 2025	AwardD	4,418	0.00 USD	$0	SEC
Nuvalent, Inc.	Dec 11, 2025	Award	2,837	0.00 USD	$0	SEC
ADC TELECOMMUNICATIONS INC	Jun 17, 2025	Other	-15,184	3.58 USD	$54.4K	SEC
ADC TELECOMMUNICATIONS INC	Jun 5, 2025	Award	40,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 16, 2025	Award	6,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 16, 2025	AwardD	19,500	0.00 USD	$0	SEC
ADC TELECOMMUNICATIONS INC	Jun 18, 2024	Sell	-6,995	2.89 USD	$20.2K	SEC
ADC TELECOMMUNICATIONS INC	Jun 14, 2024	Award	40,000	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-3,269	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-9,570	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-18,500	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-4,727	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD	-30,000	—	—	SEC
Travere Therapeutics, Inc.	May 10, 2024	Award	6,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 10, 2024	AwardD	19,500	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jan 18, 2024	AwardD	4,727	10.58 USD	$50K	SEC
Deciphera Pharmaceuticals, Inc.	Jun 23, 2023	AwardD	30,000	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 19, 2023	Award	4,500	0.00 USD	$0	SEC
Travere Therapeutics, Inc.	May 19, 2023	AwardD	13,500	0.00 USD	$0	SEC
Deciphera Pharmaceuticals, Inc.	Jan 19, 2023	AwardD	3,269	15.30 USD	$50K	SEC